€9.17
1.78% yesterday
Frankfurt, Nov 15, 08:18 am CET
ISIN
SE0017769995
Symbol
BGLA
Sector
Industry

BioGaia Stock price

€9.17
-0.16 1.66% 1M
-2.14 18.89% 6M
+0.46 5.26% YTD
+0.50 5.72% 1Y
-0.58 5.93% 3Y
+2.67 41.03% 5Y
+5.67 162.11% 10Y
Frankfurt, Closing price Fri, Nov 15 2024
+0.16 1.78%
ISIN
SE0017769995
Symbol
BGLA
Sector
Industry

Key metrics

Market capitalization €927.15m
Enterprise Value €828.63m
P/E (TTM) P/E ratio 31.37
EV/FCF (TTM) EV/FCF 25.54
EV/Sales (TTM) EV/Sales 6.98
P/S ratio (TTM) P/S ratio 7.81
P/B ratio (TTM) P/B ratio 6.48
Dividend yield 1.80%
Last dividend (FY23) €0.59
Revenue growth (TTM) Revenue growth 5.74%
Revenue (TTM) Revenue €118.66m
EBIT (operating result TTM) EBIT €35.67m
Free Cash Flow (TTM) Free Cash Flow €32.45m
Cash position €98.52m
EPS (TTM) EPS €0.29
Show more

Is BioGaia a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Financial data from BioGaia

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
119 119
6% 6%
100%
- Direct Costs 31 31
5% 5%
26%
87 87
6% 6%
74%
- Selling and Administrative Expenses 32 32
3% 3%
27%
- Research and Development Expense 13 13
37% 37%
11%
42 42
6% 6%
36%
- Depreciation and Amortization 6.69 6.69
204% 204%
6%
EBIT (Operating Income) EBIT 36 36
5% 5%
30%
Net Profit 30 30
24% 24%
25%

In millions EUR.

Don't miss a Thing! We will send you all news about BioGaia directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Theresa Agnew
Employees 210
Founded 1990
Website www.biogaia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today